845 related articles for article (PubMed ID: 28648661)
1. De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation.
Ghoneim HE; Fan Y; Moustaki A; Abdelsamed HA; Dash P; Dogra P; Carter R; Awad W; Neale G; Thomas PG; Youngblood B
Cell; 2017 Jun; 170(1):142-157.e19. PubMed ID: 28648661
[TBL] [Abstract][Full Text] [Related]
2. Subsets of exhausted CD8
Miller BC; Sen DR; Al Abosy R; Bi K; Virkud YV; LaFleur MW; Yates KB; Lako A; Felt K; Naik GS; Manos M; Gjini E; Kuchroo JR; Ishizuka JJ; Collier JL; Griffin GK; Maleri S; Comstock DE; Weiss SA; Brown FD; Panda A; Zimmer MD; Manguso RT; Hodi FS; Rodig SJ; Sharpe AH; Haining WN
Nat Immunol; 2019 Mar; 20(3):326-336. PubMed ID: 30778252
[TBL] [Abstract][Full Text] [Related]
3. Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion.
Ahn E; Youngblood B; Lee J; Lee J; Sarkar S; Ahmed R
J Virol; 2016 Oct; 90(19):8934-46. PubMed ID: 27466420
[TBL] [Abstract][Full Text] [Related]
4. Dual Relief of T-lymphocyte Proliferation and Effector Function Underlies Response to PD-1 Blockade in Epithelial Malignancies.
Balança CC; Scarlata CM; Michelas M; Devaud C; Sarradin V; Franchet C; Martinez Gomez C; Gomez-Roca C; Tosolini M; Heaugwane D; Lauzéral-Vizcaino F; Mir-Mesnier L; Féliu V; Valle C; Pont F; Ferron G; Gladieff L; Motton S; Tanguy Le Gac Y; Dupret-Bories A; Sarini J; Vairel B; Illac C; Siegfried-Vergnon A; Mery E; Fournié JJ; Vergez S; Delord JP; Rochaix P; Martinez A; Ayyoub M
Cancer Immunol Res; 2020 Jul; 8(7):869-882. PubMed ID: 32295784
[TBL] [Abstract][Full Text] [Related]
5. CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.
Hashimoto M; Kamphorst AO; Im SJ; Kissick HT; Pillai RN; Ramalingam SS; Araki K; Ahmed R
Annu Rev Med; 2018 Jan; 69():301-318. PubMed ID: 29414259
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral Tcf1
Siddiqui I; Schaeuble K; Chennupati V; Fuertes Marraco SA; Calderon-Copete S; Pais Ferreira D; Carmona SJ; Scarpellino L; Gfeller D; Pradervand S; Luther SA; Speiser DE; Held W
Immunity; 2019 Jan; 50(1):195-211.e10. PubMed ID: 30635237
[TBL] [Abstract][Full Text] [Related]
7. Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells.
Bae EA; Seo H; Kim BS; Choi J; Jeon I; Shin KS; Koh CH; Song B; Kim IK; Min BS; Han YD; Shin SJ; Kang CY
Cancer Res; 2018 Sep; 78(18):5315-5326. PubMed ID: 30012672
[TBL] [Abstract][Full Text] [Related]
8. Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade.
Wei SC; Levine JH; Cogdill AP; Zhao Y; Anang NAS; Andrews MC; Sharma P; Wang J; Wargo JA; Pe'er D; Allison JP
Cell; 2017 Sep; 170(6):1120-1133.e17. PubMed ID: 28803728
[TBL] [Abstract][Full Text] [Related]
9. Premature terminal exhaustion of Friend virus-specific effector CD8+ T cells by rapid induction of multiple inhibitory receptors.
Takamura S; Tsuji-Kawahara S; Yagita H; Akiba H; Sakamoto M; Chikaishi T; Kato M; Miyazawa M
J Immunol; 2010 May; 184(9):4696-707. PubMed ID: 20351188
[TBL] [Abstract][Full Text] [Related]
10. Programmed cell death 1-directed immunotherapy for enhancing T-cell function.
Araki K; Youngblood B; Ahmed R
Cold Spring Harb Symp Quant Biol; 2013; 78():239-47. PubMed ID: 25028401
[TBL] [Abstract][Full Text] [Related]
11. Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity.
Kuehm LM; Wolf K; Zahour J; DiPaolo RJ; Teague RM
Cancer Immunol Immunother; 2019 Jul; 68(7):1095-1106. PubMed ID: 31104075
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic intervention in cancer and chronic viral infections: antibody mediated manipulation of PD-1/PD-L1 interaction.
Sakthivel P; Gereke M; Bruder D
Rev Recent Clin Trials; 2012 Feb; 7(1):10-23. PubMed ID: 22023178
[TBL] [Abstract][Full Text] [Related]
13. Modeling tumor immunity of mouse glioblastoma by exhausted CD8
Nakashima H; Alayo QA; Penaloza-MacMaster P; Freeman GJ; Kuchroo VK; Reardon DA; Fernandez S; Caligiuri M; Chiocca EA
Sci Rep; 2018 Jan; 8(1):208. PubMed ID: 29317703
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells.
Wang S; Campos J; Gallotta M; Gong M; Crain C; Naik E; Coffman RL; Guiducci C
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):E7240-E7249. PubMed ID: 27799536
[TBL] [Abstract][Full Text] [Related]
15. Lack of CD8
Horton BL; Morgan DM; Momin N; Zagorulya M; Torres-Mejia E; Bhandarkar V; Wittrup KD; Love JC; Spranger S
Sci Immunol; 2021 Oct; 6(64):eabi8800. PubMed ID: 34714687
[TBL] [Abstract][Full Text] [Related]
16. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of T cell exhaustion.
Belk JA; Daniel B; Satpathy AT
Nat Immunol; 2022 Jun; 23(6):848-860. PubMed ID: 35624210
[TBL] [Abstract][Full Text] [Related]
18. Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.
Youngblood B; Oestreich KJ; Ha SJ; Duraiswamy J; Akondy RS; West EE; Wei Z; Lu P; Austin JW; Riley JL; Boss JM; Ahmed R
Immunity; 2011 Sep; 35(3):400-12. PubMed ID: 21943489
[TBL] [Abstract][Full Text] [Related]
19. Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.
Liu J; Zhang S; Hu Y; Yang Z; Li J; Liu X; Deng L; Wang Y; Zhang X; Jiang T; Lu X
J Immunother; 2016 May; 39(4):171-80. PubMed ID: 27070448
[TBL] [Abstract][Full Text] [Related]
20. Cell-Intrinsic Barriers of T Cell-Based Immunotherapy.
Ghoneim HE; Zamora AE; Thomas PG; Youngblood BA
Trends Mol Med; 2016 Dec; 22(12):1000-1011. PubMed ID: 27825667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
